Kintara Therapeutics to Present at BIO CEO & Investor Conference on February 15, 2022
SAN DIEGO, Feb. 4, 2022 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its President and Chief Executive Officer, Robert E. Hoffman will present a corporate…
Comments Off on Kintara Therapeutics to Present at BIO CEO & Investor Conference on February 15, 2022